Tuesday, Sep 16th
Last update09:33:05 PM GMT
Former U.S. President Bill Clinton and drugmakers Pfizer and Matrix Laboratories Ltd announced a deal on Thursday to lower the cost of treatments for patients with drug-resistant forms of HIV/AIDS.
Second-line antiretroviral therapies and a drug used to treat tuberculosis for those with drug-resistant HIV/AIDS will be made available at a reduced cost and in more convenient regimens, saving as many as hundreds of thousands of lives in the developing world.
 The disruptions were also sex-specific — affecting donor liver cells of males and females in different... |
 A measure that would allow Texas residents to sue out-of-state abortion pill providers advanced to the... | ||
 Throughout the last two years, Gaza has faced widespread destruction as a result of Israel’s ongoing... |
 The U.S. is seeing a late summer surge in COVID-19 cases, tracking from the Centers for... |
